Emergency Medicine Doctors in Morgan City, LA Accepting Medicare

8 Emergency Medicine doctors found. Showing 1 - 8

Dr. Juan Santiago Blanch, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1125 Marguerite St, Morgan City, LA 70380 Phone: 504-866-1336

Donald P Thibodaux, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 Kenneth St, Morgan City, LA 70380 Phone: 985-384-3355    Fax: 985-384-2884

Morris Alan Sandler, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1125 Marguerite St, Morgan City, LA 70380 Phone: 985-380-4434

Dr. Majid Jawad, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1125 Marguerite St, Morgan City, LA 70380 Phone: 504-432-6917

Robert M Bourgeois, MD MPH Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 Kenneth St, Morgan City, LA 70380 Phone: 985-384-3355    Fax: 985-384-2884

Dr. Timothy Sean Magann, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1125 Marguerite St, Morgan City, LA 70380 Phone: 985-380-4434    Fax: 985-380-4344

Dr. Phillip L Lebas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1125 Marguerite St, Morgan City, LA 70380 Phone: 985-384-2200

Francis H Metz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1125 Marguerite St, Morgan City, LA 70380 Phone: 800-893-9698

News Archive

Ischemic postconditioning for STEMI patients shows no clinical outcomes

A large randomized controlled trial of ischemic postconditioning in patients who had experienced the deadliest form of heart attack—ST-segment elevation myocardial infarction (STEMI)—failed to show that this procedure significantly reduces death from any cause or hospitalization for heart failure, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

EC grants marketing authorization for Taiho's Teysuno to treat gastric cancer

Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the European Commission has granted marketing authorization for Teysuno, a novel oral anti-cancer agent indicated for the treatment of adults with advanced gastric cancer when given in combination with cisplatin.

Aerobic exercise could help wounded warriors recover from mild traumatic brain injury

Improvised explosive devices and associated blast injuries have left over 350,000 U.S. service members in Iraq and Afghanistan with an invisible wound: traumatic brain injury.

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

Silence Therapeutics plc a leading global RNA interference therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology Annual Meeting.

Read more Medical News

› Verified 8 days ago